Synbiotics decrease the incidence of septic complications in patients with severe SIRS: A preliminary report

Digestive Diseases and Sciences

Volumn 54, Issue 5, 2009, Pages 1071-1078

  Shimizu, Kentaro ^a   Ogura, Hiroshi ^a   Goto, Miki ^a   Asahara, Takashi ^b   Nomoto, Koji ^b   Morotomi, Masami ^b   Matsushima, Asako ^a   Tasaki, Osamu ^a   Fujita, Kieko ^a   Hosotsubo, Hideo ^a   Kuwagata, Yasuyuki ^a   Tanaka, Hiroshi ^a   Shimazu, Takeshi ^a   Sugimoto, Hisashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Flora; Gut; pH; Probiotics; Short chain fatty acid; SIRS; Synbiotics

Indexed keywords

BIFIDOBACTERIUM BREVE EXTRACT; C REACTIVE PROTEIN; GALACTOSE OLIGOSACCHARIDE; LACTOBACILLUS CASEI EXTRACT; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT;

ADULT; ARTICLE; BACTEREMIA; BIFIDOBACTERIUM BREVE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; FECES ANALYSIS; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; INFECTION RATE; INTESTINE FLORA; LACTOBACILLUS CASEI; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BIFIDOBACTERIUM; C-REACTIVE PROTEIN; FATTY ACIDS; FECES; FEMALE; HUMANS; INCIDENCE; INTESTINES; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PILOT PROJECTS; PROBIOTICS; SEPSIS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 63949084824     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0460-2     Document Type: Article

References (41)

1. F Guarner JR Malagelada 2003 Gut flora in health and disease Lancet 361 512 519 10.1016/S0140-6736(03)12489-0
2. J MacFie C O'Boyle CJ Mitchell PM Buckley D Johnstone P Sudworth 1999 Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity Gut 45 223 228
3. A Hart MA Kamm 2002 Review article: mechanisms of initiation and perpetuation of gut inflammation by stress Aliment Pharmacol Ther 16 2017 2028 10.1046/j.1365-2036.2002.01359.x
4. K Shimizu H Ogura M Goto 2006 Altered gut flora and environment in patients with severe sirs J Trauma 60 126 133 10.1097/01.ta.0000197374.99755.fe
5. R Fuller 1989 Probiotics in man and animals J Appl Bacteriol 66 365 378
6. K Nomoto 2005 Prevention of infections by probiotics J Biosci Bioeng. 100 583 592 10.1263/jbb.100.583
7. GR Gibson 1998 Dietary modulation of the human gut microflora using prebiotics Br J Nutr. 80 S209 S12
8. M Ito Y Deguchi K Matsumoto M Kimura N Onodera T Yajima 1993 Influence of galactooligosaccharides on the human fecal microflora J Nutr Sci Vitaminol (Tokyo) 39 635 640
9. N Rayes D Seehofer T Theruvath 2005 Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial Am J Transplant 5 125 130 10.1111/j.1600-6143.2004.00649.x
10. K Kotzampassi EJ Giamarellos-Bourboulis A Voudouris P Kazamias E Eleftheriadis 2006 Benefits of a synbiotic formula (synbiotic 2000forte) in critically ill trauma patients: early results of a randomized controlled trial World J Surg 30 1848 1855 10.1007/s00268-005-0653-1
11. A Olah T Belagyi A Issekutz ME Gamal S Bengmark 2002 Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis Br J Surg 89 1103 1107 10.1046/j.1365-2168. 2002.02189.x
12. MG Besselink HC van Santvoort E Buskens 2008 Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371 651 659 10.1016/S0140-6736(08)60207-X
13. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
14. Azuma R, Suto T. Validity of transfer of the taxonomical position of Corynebacterium pseudopyogenes from genus Corynebacterium to genus Actinomyces. In: Izuka H, Hasegawa T, eds. Proceeding of the First International Conference on Culture Collection. Tokyo:University of Tokyo Press, 1970:493-505.
15. Mitsuoka T, Ono K. Fecal flora of man. V. communication: the fluctuation of the fecal flora of the healthy adult (author's transl. Orig A). Zentralbl Bakteriol. 1977;238:228-236.
16. WE Moore EP Cato LV Holdeman 1978 Some current concepts in intestinal bacteriology Am J Clin Nutr 31 S33 S42
17. R Tanaka M Mutai 1980 Improved medium for selective isolation and enumeration of Bifidobacterium Appl Environ Microbiol 40 866 869
18. DN Petts 1984 Colistin-oxolinic acid-blood agar: a new selective medium for streptococci J Clin Microbiol 19 4 7
19. H Kikuchi T Yajima 1992 Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats J Sci Food Agric 60 139 146 10.1002/jsfa.2740600202
20. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance System (NNIS). Available at http://www.cdc.gov/ncidod/ dhqp/nnis-pubs.html. Accessed 21 Feb 2008.
21. EJ Vollaard HA Clasener 1994 Colonization resistance Antimicrob Agents Chemother 38 409 414
22. WE Moore LH Moore 1995 Intestinal floras of populations that have a high risk of colon cancer Appl Environ Microbiol 61 3202 3207
23. RK Linskens XW Huijsdens PH Savelkoul CM Vandenbroucke-Grauls SG Meuwissen 2001 The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics Scand J Gastroenterol Suppl 234 29 40 10.1080/003655201753265082
24. B Bjorksten 2004 Effects of intestinal microflora and the environment on the development of asthma and allergy Springer Semin Immunopathol 25 257 270 10.1007/s00281-003-0142-2
25. E Furrie S Macfarlane A Kennedy JH Cummings SV Walsh DA O'Neil 2005 Synbiotic therapy (bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial Gut 54 242 249 10.1136/gut.2004.044834
26. Q Liu ZP Duan DK Ha S Bengmark J Kurtovic SM Riordan 2004 Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 1441 1449 10.1002/hep.20194
27. Y Kanamori K Hashizume M Sugiyama M Morotomi N Yuki 2001 Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure Dig Dis Sci 46 2010 2016 10.1023/A:1010611920750
28. H Kanazawa M Nagino S Kamiya S Komatsu T Mayumi K Takagi 2005 Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy Langenbecks Arch Surg 390 104 113 10.1007/s00423-004-0536-1
29. AD Anderson CE McNaught PK Jain J MacFie 2004 Randomised clinical trial of synbiotic therapy in elective surgical patients Gut 53 241 245 10.1136/gut.2003.024620
30. PK Jain CE McNaught AD Anderson J MacFie CJ Mitchell 2004 Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial Clin Nutr 23 467 475 10.1016/j.clnu.2003.12.002
31. PJ Watkinson VS Barber P Dark JD Young 2007 The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review Clin Nutr 26 182 192 10.1016/j.clnu.2006.07.010
32. T Matsuzaki J Chin 2000 Modulating immune responses with probiotic bacteria Immunol Cell Biol 78 67 73 10.1046/j.1440-1711.2000.00887.x
33. T Asahara K Shimizu K Nomoto T Hamabata A Ozawa Y Takeda 2004 Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7 Infect Immun 72 2240 2247 10.1128/IAI.72.4.2240-2247. 2004
34. T Asahara K Nomoto K Shimizu M Watanuki R Tanaka 2001 Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides J Appl Microbiol 91 985 996 10.1046/j.1365-2672.2001.01461.x
35. H Yasui J Kiyoshima T Hori 2004 Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota Clin Diagn Lab Immunol 11 675 679 10.1128/CDLI.11.4.675-679.2004
36. A Tsunoda M Shibusawa Y Tsunoda M Watanabe K Nomoto M Kusano 2002 Effect of Lactobacillus casei on a novel murine model of abdominal sepsis J Surg Res 107 37 43
37. Remesy C, Demigne C, Morand C. Metabolism of short chain fatty acids in the liver. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge: Cambridge University Press; 1995:171-190.
38. SE Pryde SH Duncan GL Hold CS Stewart HJ Flint 2002 The microbiology of butyrate formation in the human colon FEMS Microbiol Lett 217 133 139 10.1111/j.1574-6968.2002.tb11467.x
39. L Yin G Laevsky C Giardina 2001 Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity J Biol Chem 276 44641 44646 10.1074/jbc.M105170200
40. Y Kanamori K Hashizume M Sugiyama M Mortomi N Yuki R Tanaka 2002 A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (ltec) in the intensive care unit Clin Nutr 21 527 530 10.1054/clnu.2002.0593
41. J Fallingborg 1999 Intraluminal pH of the human gastrointestinal tract Dan Med Bull 46 183 196